GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (XSWX:BION) » Definitions » Gross Loan

BB Biotech AG (XSWX:BION) Gross Loan : CHF0.0 Mil (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is BB Biotech AG Gross Loan?

BB Biotech AG's Gross Loan for the quarter that ended in Sep. 2024 was CHF0.0 Mil.


BB Biotech AG Gross Loan Historical Data

The historical data trend for BB Biotech AG's Gross Loan can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Gross Loan Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Loan
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BB Biotech AG Quarterly Data
Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Loan Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BB Biotech AG Gross Loan Calculation

Gross Loan represents the sum of all loans (commercial, consumer, mortgage, etc.) as well as leases before any provisions for loan losses or unearned discounts.


BB Biotech AG Gross Loan Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Gross Loan provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG Business Description

Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system.
Executives
Dr. Thomas Von Planta Supervisory Board
Prof. Dr. Mads Krogsgaard Thomsen Supervisory Board

BB Biotech AG Headlines

No Headlines